We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Prognostic Value of Blood Cell Counts Investigated

By LabMedica International staff writers
Posted on 29 Oct 2018
The prognosis and treatment of gastric cancer patients after radical gastrectomy mainly depends on classification of malignant tumors (TNM) stage system. However, the prognosis of gastric cancer patients could be various even with the same tumor stage.

Over the past decades, prognostic value of blood test parameters in gastric cancer patients has been investigated by numerous studies, because a blood test is simple, convenient, reproducible and cost-effective. However, the most common parameters been investigated in the previous reports were neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR).

Image: A blood smear showing various leukocytes used to assess the complete white blood cell count by microscopy (Photo courtesy of the University of Minnesota).
Image: A blood smear showing various leukocytes used to assess the complete white blood cell count by microscopy (Photo courtesy of the University of Minnesota).

Medical scientists at the Fourth Military Medical University (Xi’an, China) enrolled a total of 3,243 gastric cancer patients from September 2008 to March 2015. There were 2,538 male and 705 female and the median age was 58 years (range 20–90). The median follow-up time was 24.9 months (range 1–75). All patients were treated with radical D2 gastrectomy, defined as a dissection of all the Group 1 and Group 2 nodes, and regular follow up.

Preoperative blood test was performed within seven days before surgery. Absolute count of white blood cells or leukocytes (WBC), neutrophil, lymphocyte, monocyte and platelet were recorded. Patients with signs of infection were excluded. Clinicopathological data including gender, age, tumor location, tumor size, pathological type, tumor depth, lymph node metastasis and tumor stage were collected. The patients were followed up until November 2015 every three months.

The team reported that the statistically significant optimal cut off value was 6.19 × 109/L for WBC, 4.19 × 109/L for neutrophils, 1.72 × 109/L for lymphocytes, 0.51 × 109/L for monocytes, and 260 × 109/L for platelets, respectively. Neutrophil, lymphocyte, monocyte and platelet were risk factors for the prognosis of gastric cancer. However, only lymphocyte and monocyte were independent risk factors. Combination of lymphocyte and monocyte counts could increase the prognostic value for gastric cancer patients, especially in stage II/III gastric cancer patients.

The authors concluded that absolute count of blood cells was more convenient in predicting the prognosis of gastric cancer patients. High absolute count of neutrophil, monocyte and platelet, and low absolute count of lymphocyte were associated with poor prognosis of gastric cancer. However, only lymphocyte and monocyte count were independent prognostic predictors. The study was published on October 11, 2018, in the journal BMC Gastroenterology.

Related Links:
Fourth Military Medical University


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Automated Blood Typing System
IH-500 NEXT
New
Human Insulin CLIA
Human Insulin CLIA Kit
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA

Latest Hematology News

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients